RUA Life Sciences PLC Buy Back and Cancellation of Deferred Shares (0383D)
24 Junio 2021 - 7:01AM
UK Regulatory
TIDMRUA
RNS Number : 0383D
RUA Life Sciences PLC
24 June 2021
24 June 2021
RUA Life Sciences plc
("RUA" or the "Company")
Buy Back and Cancellation of Deferred Shares
Further to its announcement released on 23 June 2021, RUA Life
Sciences plc (AIM: RUA), the holding company of a group of medical
device businesses focused on the exploitation of Elast-Eon(TM) , a
long-term implantable biostable polymer, is pleased to announce
that the Company has completed the Buy Back of all of its Deferred
Shares, details of which were set out in the Circular sent to
Shareholders dated 4 June 2021. All of the Deferred Shares acquired
have been cancelled. Following the repurchase and cancellation of
the Deferred Shares, there are no Deferred Shares in issue and the
New Articles have been adopted.
The Company's issued share capital following completion of the
Buy Back of all of its Deferred Shares comprises 22,184,798
Ordinary Shares of which none are held in treasury. The above
figure of 22,184,798 may be used by Shareholders as the
denomination for the calculations by which they will determine if
they are required to notify their interest or a change in their
interest in the voting rights in the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Unless otherwise defined herein, capitalised terms used in this
announcement shall have the same meanings as defined in the
Circular sent to Shareholders dated 4 June 2021.
For more information please contact:
RUA Life Sciences plc
Bill Brown, Chairman Tel: +44 (0) 77 3071 8296
David Richmond, CEO Tel: +44 (0) 78 9999 6400
Shore Capital (Nomad and Joint Broker)
Tom Griffiths/David Coaten Tel: +44 (0) 20 7408 4080
Cenkos Securities plc (Joint Broker) Tel: +44 (0) 20 7397 8900
Russell Cook/Max Gould (Corporate Finance)
Michael Johnson (Sales)
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when RUA
Life Sciences Plc (formerly known as AorTech International Plc)
acquired RUA Medical Devices Limited to create a fully formed
medical device business. RUA Life Sciences is the holding company
of the Group's four trading businesses, each exploiting the Group's
patented polymer technology.
Our vision is to improve the lives of millions of patients by
improving and enabling medical devices with Elast-Eon(TM), a
long-term implantable polyurethane.
Whether it is licensing Elast-Eon(TM), manufacturing a device or
component or developing next generation medical devices, a RUA Life
Sciences business is pursuing our vision.
Elast-Eon(TM)'s biostability is comparable to silicone while
exhibiting excellent mechanical, blood contacting and flex-fatigue
properties. These polymers can be processed using conventional
thermoplastic extrusion and moulding techniques. With over 7
million implants and over 14 years of successful clinical use,
RUA's polymers are proven in long-term life enabling
applications.
The Group's four business units are:
RUA Medical : End-to-end contract designer and manufacturer
of medical devices and implantable fabric specialist.
RUA Biomaterials: Licensor of Elast-Eon(TM) polymers to the medical
device industry.
RUA Vascular: Commercialisation of large bore polymer sealed
grafts and soft tissue patches.
RUA Structural Development of polymeric leaflet systems for
Heart: heart valves.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSUSVARAKUNUAR
(END) Dow Jones Newswires
June 24, 2021 08:01 ET (12:01 GMT)
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024